BRPI0514903A - proteìnas vegetais ou leite fermentado compreendendo ligando de receptor e uso dos mesmos - Google Patents

proteìnas vegetais ou leite fermentado compreendendo ligando de receptor e uso dos mesmos

Info

Publication number
BRPI0514903A
BRPI0514903A BRPI0514903-7A BRPI0514903A BRPI0514903A BR PI0514903 A BRPI0514903 A BR PI0514903A BR PI0514903 A BRPI0514903 A BR PI0514903A BR PI0514903 A BRPI0514903 A BR PI0514903A
Authority
BR
Brazil
Prior art keywords
vegetable proteins
receptor ligand
fermented milk
mammal
relief
Prior art date
Application number
BRPI0514903-7A
Other languages
English (en)
Inventor
Benedicte Flambard
Original Assignee
Hansens Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hansens Lab filed Critical Hansens Lab
Publication of BRPI0514903A publication Critical patent/BRPI0514903A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Botany (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Medical Informatics (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)

Abstract

PROTEìNAS VEGETAIS OU LEITE FERMENTADO COMPREENDENDO LIGANDO DE RECEPTOR E USO DOS MESMOS A presente invenção refere-se ao uso de composições compreendendo ligandos de receptor alcançáveis por um processo compreendendo a fermentação de um material de alimento, compreendendo proteínas vegetais ou leite animal, com bactérias de ácido lático para obter um material de alimentação ou alimento fermentado que compreende ligandos de adrenor-receptores específicos e/ou receptores de serotonina. O material de alimentação ou alimento fermentado é útil, por exemplo, para reduzir e/ou estabilizar a freqüência cardíaca em um mamífero. Pode, além disso, ser empregado para o tratamento e/ou alivio de disfunções eréteis e para tratamento e/ou alivio de hipertrofia prostática benigna (BPH), em um mamífero.
BRPI0514903-7A 2004-09-03 2005-09-05 proteìnas vegetais ou leite fermentado compreendendo ligando de receptor e uso dos mesmos BRPI0514903A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200401339 2004-09-03
PCT/EP2005/054363 WO2006024673A1 (en) 2004-09-03 2005-09-05 Fermented milk or vegetable proteins comprising receptor ligand and uses thereof

Publications (1)

Publication Number Publication Date
BRPI0514903A true BRPI0514903A (pt) 2008-06-24

Family

ID=35344722

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0514903-7A BRPI0514903A (pt) 2004-09-03 2005-09-05 proteìnas vegetais ou leite fermentado compreendendo ligando de receptor e uso dos mesmos

Country Status (12)

Country Link
US (2) US7883697B1 (pt)
EP (1) EP1796480B1 (pt)
JP (1) JP2008511593A (pt)
CN (1) CN101035433B (pt)
AT (1) ATE532416T1 (pt)
AU (1) AU2005279163B2 (pt)
BR (1) BRPI0514903A (pt)
CA (1) CA2577613C (pt)
DK (1) DK1796480T3 (pt)
NZ (1) NZ554278A (pt)
RU (1) RU2403051C2 (pt)
WO (1) WO2006024673A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1796480T3 (da) * 2004-09-03 2012-02-13 Chr Hansen As Fermenterede mælkeproteiner, der omfatter receptor-ligand, og anvendelser deraf
JP2009046456A (ja) * 2007-08-23 2009-03-05 Kikkoman Corp 生殖行動の誘発用組成物
ITTO20110631A1 (it) * 2010-07-15 2012-01-16 Oleg Iliich Epshtein Composizione farmaceutica di combinazione e metodi per trattare patologie del sistema genitourinario
FR2962656A1 (fr) 2010-07-15 2012-01-20 Oleg Iliich Epshtein Procede pour augmenter l'effet d'une forme activee-potentialisee d'un anticorps
ITPI20110033A1 (it) * 2011-04-01 2012-10-02 Funcional Food Res S R L Preparazione alimentare funzionale ad uso maschile.
FI126711B (fi) * 2011-10-12 2017-04-13 Gut Guide Oy Serotoniinivajeeseen liittyvän terveysriskin arvioiminen
WO2016182053A1 (ja) 2015-05-13 2016-11-17 アサヒカルピスウェルネス株式会社 運動時の心拍数上昇抑制方法及び心拍数上昇抑制組成物

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5436264A (en) * 1993-08-19 1995-07-25 Syntex (U.S.A.) Inc. N-aryloxyalkyl tryptamine α1 -adrenergic receptor antagonists
US5637617A (en) * 1994-04-01 1997-06-10 The Regents Of The University Of California Methods for use of GABAa receptor GABAergic compounds
US7048906B2 (en) * 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
US6861053B1 (en) * 1999-08-11 2005-03-01 Cedars-Sinai Medical Center Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
WO1998043498A1 (fr) * 1997-04-01 1998-10-08 Nichimo Co., Ltd. Produit comprenant un ingredient favorable a la sante et son procede de production
US5854029A (en) 1996-08-02 1998-12-29 Calpis Co., Ltd. Method for preparing antihypertensive agent
JP4065038B2 (ja) * 1996-08-07 2008-03-19 カルピス株式会社 計算作業負荷ストレス緩和剤
JP3028411B2 (ja) 1997-09-26 2000-04-04 カルピス株式会社 トリペプチド高生産性ラクトバチルス・ヘルベチカス乳酸菌
FI113741B (fi) 1999-11-01 2004-06-15 Valio Oy Menetelmä verenpainetta alentavia peptidejä sisältävän tuotteen valmistamiseksi
CA2415688A1 (en) 2000-05-08 2001-11-15 Anand Rao Enzymatic treatment of whey proteins for the production of antihypertensive peptides, the resulting products and treatment of hypertension in mammals
US20020182274A1 (en) * 2001-03-21 2002-12-05 Kung-Ming Lu Methods for inhibiting cancer growth, reducing infection and promoting general health with a fermented soy extract
WO2003082019A2 (en) * 2002-04-03 2003-10-09 Chr. Hansen A/S Peptides with anti-hypertensive properties
US20040077624A1 (en) * 2002-05-23 2004-04-22 Pfizer Inc. Novel combination
CN100451127C (zh) * 2002-08-09 2009-01-14 科·汉森有限公司 制备具有抗高血压特性的肽的方法
DK1796480T3 (da) * 2004-09-03 2012-02-13 Chr Hansen As Fermenterede mælkeproteiner, der omfatter receptor-ligand, og anvendelser deraf

Also Published As

Publication number Publication date
RU2403051C2 (ru) 2010-11-10
CA2577613A1 (en) 2006-03-09
EP1796480A1 (en) 2007-06-20
WO2006024673A1 (en) 2006-03-09
JP2008511593A (ja) 2008-04-17
CA2577613C (en) 2015-12-15
ATE532416T1 (de) 2011-11-15
DK1796480T3 (da) 2012-02-13
AU2005279163A1 (en) 2006-03-09
US20110195891A1 (en) 2011-08-11
EP1796480B1 (en) 2011-11-09
AU2005279163B2 (en) 2012-02-02
CN101035433A (zh) 2007-09-12
CN101035433B (zh) 2011-09-07
US8367604B2 (en) 2013-02-05
US7883697B1 (en) 2011-02-08
NZ554278A (en) 2009-11-27
RU2007112116A (ru) 2008-10-10

Similar Documents

Publication Publication Date Title
BRPI0514903A (pt) proteìnas vegetais ou leite fermentado compreendendo ligando de receptor e uso dos mesmos
EA201071136A1 (ru) Способ получения стабильного натурального красителя, продукты и их применение
EP2674165A3 (en) Hepatocyte growth factor receptor agonist for increasing lymphangiogenesis
MA29741B1 (fr) Procede de preparation des oeufs ovules d'animaux aquatiques pour obtenir des denrees alimentaires fines et oeufs ovules ainsi prepares
WO2012002714A3 (ko) 폴리페놀과 에스-알릴시스테인이 강화된 흑마늘 및 그 제조방법
NO20051993L (no) Framgangsmate og fôr for reduksjon av innholdet av uonskede naeringsstoffer i avlopsvann fra fiskeoppdrettsanlegg
UA107559C2 (uk) Спосіб приготування гідролізату
ATE499362T1 (de) 3,5-disubstituierte pyrid-2-one, die als hemmer der tec-familie von nicht-rezeptor tyrosin- kinasen nützlich sind
CN104430163A (zh) 一种黑天鹅的饲养方法
WO2010058198A3 (en) Antimicrobial material
CN103992186B (zh) 一种工厂化瓶栽杏鲍菇培养基
GB201116841D0 (en) Methods of ensiling algae, ensiled algae and uses of ensiled algae
Devaraju et al. Studies on the physico-chemical parameters of Maddur Lake with reference to suitability for aquaculture
WO2008046993A3 (fr) Nouveau produit biologique d'origine marine, son procede d'obtention et ses utilisations
CN105541456A (zh) 一种有助于促进辣椒光合作用提高产量的高效肥料及其制备方法
CN204861110U (zh) 一种野菜加工用斩拌机
KR20160147335A (ko) 콩 가공식품의 부산물을 이용하여 얻는 가축사료의 제조방법
CN102559451A (zh) 鲜鹿血酒制作方法
RU2008111671A (ru) Способ получения биогумуса посредством ускоренной переработки куриного помета красным калифорнийским гибридом дождевого червя
Rehemujiang et al. The Cotton Stalk and Its Utilization as Ruminant Feed Resource in Xinjiang.
RU2004117658A (ru) Способ приготовления корма
RU2196438C1 (ru) Способ получения кормового продукта
Lohmann Production of Cowpeas-A manual for users and trainers (Why, Where, What, When & How)
RU2016152798A (ru) Пиво безалкогольное
CN107788279A (zh) 一种提高鲫鱼幼鱼成活率的饲料添加剂

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM OS ARTIGOS 24, 25 E 8O C/C 11 DA LPI.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.